Bochra Hakim
YOU?
Author Swipe
View article: Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines
Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines Open
Despite their wide usage in reducing tumors and improving patients' survival, chemotherapeutic drugs or natural compounds are facing the development of cancer resistance. Many experimental data and clinical trials have shown that combinato…
View article: An improved anticancer effect of 5-fluorouracil (5-FU) in combination with Prodigiosin
An improved anticancer effect of 5-fluorouracil (5-FU) in combination with Prodigiosin Open
5-fluorouracil (5-FU) is the standard of care therapy for colorectal cancer. However, complex 5-FU resistance mechanisms limit the success of this approach. Prodigiosin (PG), a secondary metabolite from various bacteria, exerts different b…